Health Care & Life Sciences » Pharmaceuticals | Mayne Pharma Group Ltd.

Mayne Pharma Group Ltd. | Key People and Executives

Scott Richards
Chief Executive Officer, Executive Director & MD
Patrick J. Blake
Director
Frank C. Condella
Director
Roger Campbell Corbett
Independent Non-Executive Chairman
William Phillip Hodges
Independent Non-Executive Director
Nancy Dolan
Independent Non-Executive Director
Bruce G. Robinson
Independent Non-Executive Director
Bruce L. Mathieson
Independent Non-Executive Director
Ronald Best
Independent Non-Executive Director
Ian Frank Scholes
Independent Non-Executive Director
Scott Richards
Chief Executive Officer, Executive Director & MD
Andrew van Breugel
Executive VP-Global Operations Excellence
Nicholas John Michael Freeman
Group Chief Financial Officer & Secretary
Ilana Stancovski
Chief Scientific Officer & Executive VP
Peter Paltoglou
Chief Development Officer, Head-M&A
Stefan J. Cross
President-International Operations
Kimberly McClintock
EVP-Metrics Contract Services
Gadi Ben Nissim
Executive Vice President-Generic Products
Patrick J. Blake
Director
Frank C. Condella
Director
Lisa Pendlebury
Vice President-Communications & Investor Relations
Kate Rintoul
Executive Vice President & General Counsel
Roger Campbell Corbett
Independent Non-Executive Chairman
William Phillip Hodges
Independent Non-Executive Director
Nancy Dolan
Independent Non-Executive Director
Bruce G. Robinson
Independent Non-Executive Director
Bruce L. Mathieson
Independent Non-Executive Director
Ronald Best
Independent Non-Executive Director
Ian Frank Scholes
Independent Non-Executive Director

About Mayne Pharma Group

View Profile
Address
1538 Main North Road
Salisbury South Australia (SA) 5106
Australia
Employees -
Website http://www.maynepharma.com
Updated 07/08/2019
Mayne Pharma Group Ltd. engages in the development and manufacture of proprietary and generic products. It operates through the following segments: Generic Products, Specialty Brands, Metrics Contract Services, and Mayne Pharma International. The Generic Products segment involves in the manufacture and distribution of generic and branded pharmaceutical products.